| Literature DB >> 32286352 |
Mingyuan Yuan1, Honglan Mi2, Xiao Wang2,3, Shiteng Suo2, Khalid Eteer4, Suqin Li2, Qing Lu5, Jianrong Xu6, Jiani Hu4.
Abstract
To investigate the diagnostic value of texture analysis (TA) for differentiating between colorectal cancer (CRC), colonic lesions caused by inflammatory bowel disease (IBD), and normal thickened colon wall (NTC) on computed tomography (CT) and assess which scanning phase has the highest differential diagnostic value. In all, 107 patients with CRC, 113 IBD patients with colonic lesions, and 96 participants with NTC were retrospectively enrolled. All subjects underwent multiphase CT examination, including pre-contrast phase (PCP), arterial phase (AP), and portal venous phase (PVP) scans. Based on these images, classification by TA and visual classification by radiologists were performed to discriminate among the three tissue types. The performance of TA and visual classification was compared. Precise TA classification results (error, 2.03-12.48%) were acquired by nonlinear discriminant analysis for CRC, IBD and NTC, regardless of phase or feature selection. PVP images showed a better ability to discriminate the three tissues by comprising the three scanning phases. TA showed significantly better performance in discriminating CRC, IBD and NTC than visual classification for residents, but there was no significant difference in classification between TA and experienced radiologists. TA could provide useful quantitative information for the differentiation of CRC, IBD and NTC on CT, particularly in PVP images.Entities:
Mesh:
Year: 2020 PMID: 32286352 PMCID: PMC7156692 DOI: 10.1038/s41598-020-62973-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The number of pixels in ROI and the thickness of colon wall.
| Scan phase | Item | A1 | A2 | B | |||
|---|---|---|---|---|---|---|---|
| The pixels in ROI | PCP | CRC | 647.96 ± 42.41 | 637.14 ± 34.42 | 675.45 ± 39.60 | 0.16 | 0.848 |
| IBD | 629.46 ± 37.66 | 632.97 ± 30.77 | 607.51 ± 29.94 | 0.07 | 0.930 | ||
| NTC | 513.13 ± 19.34 | 540.10 ± 23.61 | 557.73 ± 19.71 | 0.80 | 0.449 | ||
| AP | CRC | 724.59 ± 41.65 | 713.89 ± 37.01 | 730.48 ± 35.79 | 0.03 | 0.969 | |
| IBD | 739.65 ± 36.08 | 728.45 ± 25.56 | 723.53 ± 27.27 | 0.03 | 0.975 | ||
| NTC | 623.60 ± 20.57 | 629.52 ± 25.81 | 626.16 ± 27.10 | 0.01 | 0.990 | ||
| PVP | CRC | 757.03 ± 41.94 | 755.17 ± 39.25 | 753.06 ± 30.38 | 0.01 | 0.998 | |
| IBD | 694.12 ± 31.46 | 688.32 ± 21.67 | 680.29 ± 30.58 | 0.03 | 0.975 | ||
| NTC | 628.98 ± 25.72 | 636.05 ± 25.84 | 647.22 ± 27.83 | 0.09 | 0.917 | ||
| The mean thickness of colonic wall(mm) | PCP | CRC | 9.03 ± 2.51 | 8.78 ± 1.82 | 8.72 ± 2.48 | 0.33 | 0.172 |
| IBD | 8.49 ± 1.68 | 8.62 ± 1.48 | 8.66 ± 1.74 | 0.12 | 0.891 | ||
| NTC | 8.22 ± 1.27 | 8.24 ± 1.55 | 8.21 ± 1.28 | 0.01 | 0.991 | ||
| AP | CRC | 8.78 ± 2.78 | 8.26 ± 1.95 | 8.75 ± 2.69 | 0.87 | 0.419 | |
| IBD | 8.06 ± 1.91 | 8.10 ± 1.59 | 8.17 ± 1.86 | 0.04 | 0.960 | ||
| NTC | 8.05 ± 1.28 | 7.67 ± 1.48 | 7.88 ± 1.32 | 1.39 | 0.253 | ||
| PVP | CRC | 8.66 ± 2.86 | 8.53 ± 1.92 | 8.63 ± 2.63 | 0.05 | 0.953 | |
| IBD | 8.23 ± 2.00 | 8.40 ± 1.59 | 8.49 ± 1.78 | 0.12 | 0.890 | ||
| NTC | 7.77 ± 1.32 | 7.87 ± 1.39 | 7.83 ± 1.25 | 0.09 | 0.917 |
Note: Significant p value < 0.05; ROI, region of interest; CRC, colorectal cancer; IBD, inflammatory bowel disease; NTC, normal thickening colon; PCP, precontrast phase; AP, arterial phase; PVP, portal vein phase; A1, reader A first read; A2, reader A second read; B, reader B.
ICC value of intra- and inter observer agreement for the measurement of the pixels in ROI and the thickness of colon wall.
| Scan phase | Item | A1 vs A2 | A1 vs B | |
|---|---|---|---|---|
| The pixels in ROI | PCP | CRC | 0.78 | 0.77 |
| IBD | 0.77 | 0.76 | ||
| NTC | 0.78 | 0.75 | ||
| AP | CRC | 0.79 | 0.78 | |
| IBD | 0.79 | 0.78 | ||
| NTC | 0.76 | 0.77 | ||
| PVP | CRC | 0.80 | 0.76 | |
| IBD | 0.78 | 0.76 | ||
| NTC | 0.80 | 0.79 | ||
| The mean thickness of bowel wall | PCP | CRC | 0.81 | 0.80 |
| IBD | 0.82 | 0.78 | ||
| NTC | 0.79 | 0.77 | ||
| AP | CRC | 0.80 | 0.78 | |
| IBD | 0.77 | 0.78 | ||
| NTC | 0.83 | 0.80 | ||
| PVP | CRC | 0.86 | 0.78 | |
| IBD | 0.89 | 0.79 | ||
| NTC | 0.90 | 0.81 |
Note: ICC, intraclass correlation coefficients; ROI, region of interest; CRC, colorectal cancer; IBD, inflammatory bowel disease; NTC, normal thickening colon wall; PCP, precontrast phase; AP, arterial phase; PVP, portal vein phase; A1, reader A first read; A2, reader A second read; B, reader B.
Figure 1The reproducibility of the extracted texture features between readings A1 and A2.
Figure 2The reproducibility of the extracted texture features between readings A1 and B.
The frequencies of feature category to be selected.
| Texture parameter groups | PCP | AP | PVP |
|---|---|---|---|
| CRC vs. IBD | |||
| Histogram (n = 9) | 2 | 4 | 6 |
| COM (n = 220) | 8 | 17 | 9 |
| RLM (n = 20) | 15 | 6 | 14 |
| GrM (n = 5) | 0 | 0 | 0 |
| ARM (n = 5) | 2 | 1 | 0 |
| Wavelet (n = 16) | 3 | 2 | 1 |
| IBD vs. NTC | |||
| Histogram (n = 9) | 2 | 4 | 3 |
| COM (n = 220) | 18 | 21 | 24 |
| RLM (n = 20) | 8 | 2 | 2 |
| GrM (n = 5) | 0 | 0 | 0 |
| ARM (n = 5) | 1 | 1 | 0 |
| Wavelet (n = 16) | 1 | 2 | 1 |
| CRC vs. NTC | |||
| Histogram (n = 9) | 0 | 1 | 1 |
| COM (n = 220) | 6 | 14 | 14 |
| RLM (n = 20) | 12 | 6 | 15 |
| GrM (n = 5) | 5 | 3 | 0 |
| ARM (n = 5) | 0 | 0 | 0 |
| Wavelet (n = 16) | 7 | 6 | 0 |
| CRC. vs. IBD vs. NTC | |||
| Histogram (n = 9) | 0 | 2 | 1 |
| COM (n = 220) | 3 | 13 | 13 |
| RLM (n = 20) | 14 | 5 | 15 |
| GrM (n = 5) | 6 | 3 | 0 |
| ARM (n = 5) | 0 | 0 | 0 |
| Wavelet (n = 16) | 7 | 7 | 1 |
Note: COM, the co-occurrence matrix; RLM, the run-length matrix; GrM, the absolute gradient; ARM, the autoregressive model; CRC, colorectal cancer; IBD, inflammatory bowel disease; NTC, normal thickening colon wall; PCP, precontrast phase; AP, arterial phase; PVP, portal vein phase.
The misclassification rate (%) for discrimination between CRC, IBD and NTC on three CT scan phase images with three different classifiers based on texture features selected by Fisher, POE + ACC and MI methods.
| Scanning phase | Feature selection method | PCA | LDA | NDA |
|---|---|---|---|---|
| PCP | Fisher | 20.43 | 19.35 | 9.68 |
| POE + ACC | 20.43 | 19.35 | 6.45 | |
| MI | 18.98 | 17.20 | 6.45 | |
| AP | Fisher | 16.35 | 23.66 | 8.60 |
| POE + ACC | 16.35 | 19.13 | 8.60 | |
| MI | 15.61 | 19.13 | 4.30 | |
| PVP | Fisher | 13.05 | 15.66 | 5.38 |
| POE + ACC | 13.05 | 15.66 | 5.38 | |
| MI | 14.20 | 14.20 | 6.45 | |
| PCP | Fisher | 23.98 | 18.71 | 14.04 |
| POE + ACC | 23.98 | 18.71 | 14.04 | |
| MI | 17.54 | 15.20 | 9.36 | |
| AP | Fisher | 21.05 | 19.30 | 2.76 |
| POE + ACC | 21.05 | 19.30 | 7.02 | |
| MI | 24.56 | 25.73 | 11.70 | |
| PVP | Fisher | 22.35 | 24.71 | 8.82 |
| POE + ACC | 22.35 | 14.71 | 5.29 | |
| MI | 15.29 | 15.88 | 6.47 | |
| PCP | Fisher | 10.44 | 10.99 | 6.59 |
| POE + ACC | 23.08 | 27.47 | 13.74 | |
| MI | 7.69 | 12.64 | 4.95 | |
| AP | Fisher | 15.38 | 15.38 | 6.59 |
| POE + ACC | 20.33 | 12.09 | 4.95 | |
| MI | 20.33 | 18.13 | 7.14 | |
| PVP | Fisher | 10.50 | 6.08 | 1.66 |
| POE + ACC | 10.50 | 6.08 | 1.66 | |
| MI | 6.63 | 6.63 | 2.76 | |
| PCP | Fisher | 23.77 | 26.46 | 21.52 |
| POE + ACC | 32.29 | 47.98 | 31.26 | |
| MI | 26.91 | 30.94 | 19.28 | |
| AP | Fisher | 29.15 | 25.11 | 19.28 |
| POE + ACC | 30.04 | 29.60 | 19.28 | |
| MI | 28.70 | 34.08 | 31.84 | |
| PVP | Fisher | 19.37 | 22.97 | 12.61 |
| POE + ACC | 19.37 | 22.97 | 12.61 | |
| MI | 36.94 | 39.19 | 30.63 | |
Note: CRC, colorectal cancer; IBD, inflammatory bowel disease; NTC, normal thickening colon wall; POE + ACC, Probability of classification error and average correlation; MI, Mutual information coefficients; PCA, Principal component analysis; LDA, Linear discriminant analysis; NDA, Nonlinear discriminant analysis; PCP, precontrast phase; AP, arterial phase; PVP, portal vein phase.
Figure 3Receiver operating characteristic (ROC) curves showing the texture features classification performances in portal vein phase (PVP). CRC vs. IBD (a), IBD vs. NTC (b), CRC vs. NTC (c) and CRC vs. IBD vs. NTC (d). The area under ROC curves analysis provided in Supplementary Table B.
The comparison of the misclassification rate (MCR) between visualization and texture analysis with classifier NDA for discrimination between CRC, IBD and NTC on three phase CT scan images.
| Scanning phase | MCR (%) of TA | MCR (%) of | MCR (%) of | TA vs. | TA vs. | ||
|---|---|---|---|---|---|---|---|
| PCP | 7.53 ± 1.86 | 15.85 ± 4.56 | 31.68 ± 1.46 | 3.613 | 0.069 | 15.191 | <0.001 |
| AP | 7.17 ± 2.48 | 12.23 ± 1.39 | 27.60 ± 1.29 | 2.440 | 0.135 | 10.368 | 0.002 |
| PVP | 5.74 ± 0.36 | 9.53 ± 2.72 | 16.59 ± 1.19 | 2.769 | 0.109 | 19.112 | <0.001 |
| PCP | 12.48 ± 2.70 | 18.74 ± 1.45 | 26.81 ± 1.99 | 2.646 | 0.118 | 6.315 | 0.008 |
| AP | 7.16 ± 4.47 | 14.52 ± 1.89 | 22.76 ± 1.53 | 2.578 | 1.124 | 4.550 | 0.019 |
| PVP | 6.86 ± 1.80 | 11.81 ± 1.44 | 17.43 ± 1.57 | 2.971 | 0.097 | 7.714 | 0.007 |
| PCP | 8.43 ± 4.67 | 14.48 ± 1.18 | 26.47 ± 1.19 | 2.929 | 0.109 | 5.098 | 0.015 |
| AP | 6.23 ± 1.14 | 10.53 ± 2.65 | 25.08 ± 2.05 | 3.866 | 0.089 | 13.717 | <0.001 |
| PVP | 2.03 ± 0.64 | 9.15 ± 1.72 | 15.21 ± 1.90 | 3.951 | 0.007 | 11.896 | 0.001 |
| PCP | 24.02 ± 6.37 | 32.04 ± 1.59 | 40.77 ± 1.12 | 2.102 | 0.175 | 3.501 | 0.039 |
| AP | 23.47 ± 7.25 | 27.86 ± 2.32 | 35.82 ± 1.20 | 1.038 | 0.408 | 2.270 | 0.107 |
| PVP | 18.62 ± 10.40 | 21.19 ± 1.65 | 26.51 ± 1.65 | 0.446 | 0.699 | 1.011 | 0.386 |
Note: CRC, colorectal cancer; IBD, inflammatory bowel disease; NTC, normal thickening colon wall; NDA, Nonlinear discriminant analysis; PCP, precontrast phase; AP, arterial phase; PVP, portal vein phase; TA, Texture analysis. p < 0.05 indicates significant.
Figure 4Workflow diagram of patients screening.
Clinical and histopathological information about patients with CRC and IBD.
| Variable | n (%) |
|---|---|
| CRC | 107 |
| Male | 58 (54) |
| Female | 49 (46) |
| Average age (years) | 61.5 ± 9.2 |
| Tumor location | |
| Ileocecum | 17 (15.9) |
| Ascending colon | 14 (13.1) |
| Transverse colon | 19 (17.8) |
| Descending colon | 24 (22.4) |
| Sigmoid colon | 33 (30.8) |
| T stage | |
| T1 | 32 (29.9) |
| T2 | 29 (27.1) |
| T3 | 27 (25.2) |
| T4 | 19 (17.8) |
| Clinical grade | |
| Grade I | 27 (25.2) |
| Grade II | 58 (54.2) |
| Grade III | 22 (20.6) |
| Histological type | |
| Mucinous adenocarcinoma | 25 (23.4) |
| Tubular adenocarcinoma | 82 (76.6) |
| IBD | 113 |
| Male | 66 (58.4) |
| Female | 47 (41.6) |
| Average age (years) | 36.3 ± 10.6 |
| Duration of IBD (Months) | 38.8 ± 59.6 |
| Crohn disease | 58 (51.3) |
| Ulcerative colitis | 55 (48.7) |
| Active IBD | 36 (31.9) |
| Chronic IBD | 77 (68.1) |
Figure 5Delineation of Region of Interest (ROI) in arterial phase. (a) For colon carcinoma, (b) for ulcerative colitis, (c) for normal thickened colon wall.